chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), INTENTIONAL DOSE OMISSION (Second dose to be given more than 36 days/She did not get the second dose due to the fear of experiencing side effects), INSOMNIA (Unable to sleep), ARTHRALGIA (Extreme joint pain) and HEADACHE (Headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (Dizziness), INSOMNIA (Unable to sleep), ARTHRALGIA (Extreme joint pain), HEADACHE (Headache), VACCINATION SITE PAIN (Excruciating pain on left arm), FATIGUE (Exhaustion) and NAUSEA (Nausea). On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (Second dose to be given more than 36 days/She did not get the second dose due to the fear of experiencing side effects). On 23-Mar-2021, DIZZINESS (Dizziness), INSOMNIA (Unable to sleep), ARTHRALGIA (Extreme joint pain), HEADACHE (Headache), VACCINATION SITE PAIN (Excruciating pain on left arm), FATIGUE (Exhaustion) and NAUSEA (Nausea) had resolved. At the time of the report, INTENTIONAL DOSE OMISSION (Second dose to be given more than 36 days/She did not get the second dose due to the fear of experiencing side effects) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concurrent ad treatment medication was reported by patient.  All the event lasted for 5 days.   She was planning to get the second dose anytime as it was required by her office to do so.
Myalgia, Arthralgia & Fever Narrative:  Employee got the second covid vaccine 02/04/2021 at  3pm Employee related to worsening body ache, fever, chills missed work 2/5/2021  Other Relevant History:
10-2-3 onset of red circular rash with white center. Treat symptoms, watch for infection. Still with rash today.
Numbness on one side of body/The numbness occurred from her right ear down to her foot; This is a spontaneous report received from a contactable consumer (patient herself) via Pfizer sponsored program. A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration at left arm (at the age of 63-Years old) on 24Mar2021 (Batch/Lot number: Not Provided) as single dose for COVID-19 immunization. Medical history included tremors, multiple sclerosis from 2015 (diagnosed with Multiple Sclerosis was 6 years ago). Patient received historical vaccine flu shot and made her sleep or drowsy on an unspecified date (She does not have a date, manufacturer, lot or expiration). Concomitant medication included cefixime (FLEXERIL) for muscle relaxant at 10 mg one tablet three times daily. It was mentioned that she had a patient on the line who was on Toviaz who has Multiple Sclerosis. She is a new patient and clarified information above. She had not yet begun taking Toviaz. She cannot afford it. Patient did not have History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations and there was additional vaccines administered on same date of the Pfizer suspect. Patient do not visit the emergency room or physician office. She just sucked it up and when she saw her neurologist yesterday, he stated she should not get the second dose. She did not wish to provide her neurologist's name or contact details. No medical treatment was given. Her body just does so many screwball things, she just ignores it. Patient did not receive any other vaccinations within 4 weeks prior to the first administration date of the suspect vaccine and patient did not had family history. She did have an issue with a Pfizer COVID 19 shot. She was numb on one side of her body on 25Mar2021 at 12:00. She spoke to her neurologist and he does not want her to take the second series of the vaccine. The numbness occurred from her right ear down to her foot. She kind of freaked out after that. It occurred on the second day, which was one day after she had it. It started and went all the way up. She said the numbness is gone now. She originally provided date of first dose of 22Mar2021. She further stated the lot number was either a 5 or a G then P7534. The date on her card for second dose was originally scheduled for 14Apr2021, but she did not get it. She was scared she would go completely numb if she did and because of her Multiple Sclerosis, your body makes things like seizures and had to have a muscle relaxer. She jerks and trembles if she does not have them. She tried to do without them, she cannot. She confirmed that she got tremors before the vaccine. Outcome of the event was recovered on an unspecified date in 2021.   No follow up attempts are possible. Information about lot/batch number cannot be obtained.
After receiving the 2nd dose of the Moderna Vaccine, the following morning at 01:00 I started experiencing severe tiredness, headache, muscle pain, muscle weakness, chills, fever and nausea. These symptoms lasted for about a week before most of them subsided. After that first week, I continued to experience tiredness and weakness (flu like). On March 18, I felt as though my eyes were crossing and then on March 19, my right eye began to droop. On March 20, my right side of my face began to droop sporadically. I went to the Emergency Room on March 22 due to these symptoms and muscular weakness and was admitted. Since then, I've been diagnosed with Myasthenia Gravis and have had 4 hospital admissions (3/4 in the ICU) due to Myasthenia Crisis. I experience severe muscle weakness, breathing issues, swallowing issues and double vision. I require IVIG therapy once a week to remain stable and out of the hospital along with prednisone and other medications daily.
Patient states that every time he gets a covid vaccine, his pulse ox drops about 12-16 hours after administration. Patent's pulse ox was hovering right around 90 when he called this morning.  Patient states he is also fatigued, has a cough, and a minor sore throat.
it started falling out into my hands/ My hair is very thin now; This is a spontaneous report from a contactable Nurse (patient). A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration, administered in Arm Right on 19Mar2021 07:15 (Batch/Lot Number: Ep7534) as SINGLE DOSE for covid-19 immunisation. The patient is not pregnant at time of vaccination. Medical history included HBP and Pre-Diab both from an unknown date and unknown if ongoing (reported as Other medical history: HBP, pre-Diab). The patient had no Covid prior vaccination and not tested for Covid post vaccination. No other vaccine in four weeks. The patient was vaccinated at a clinic. Concomitant medication (reported as other medications in two weeks) included sitagliptin phosphate (JANUVIA [SITAGLIPTIN PHOSPHATE]), metformin (METFORMIN), asa (reported as 325), colecalciferol (VIT D3), metoprolol (METOPROLOL), famotidine (FAMACE); all taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 for COVID-19 immunization first dose (lot: EL8982) on 27Feb2021 at 08:00 am administered in left Arm. It was reported that "Within a few days of my 2nd shot, I was in the shower washing my hair and it started falling out into my hands. I haven't changed any hair products. I've always had nice thick hair. I told my Dr during a visit 06Apr2021, he didn't note any bald patches. My hair is very thin now, Im hoping this is temporary." It was reported that the event occurred on 21Mar2021 at 08:00 am. The outcome of the event was not recovered. The events resulted in Disability or permanent damage.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the event alopecia cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Patient requested and received booster dose of Moderna Vaccine for booster dose in error. Pharmacist on duty failed to catch age restrictions for this vaccine and administered booster. Patient experienced minor body aches, fever, headache. It all went away in 2 days.   Patients mom was notified and she confirmed daughter is ok. They will follow up with their PCP.
The roof of his mouth became sore and raw and  his tongue swelled.   He had to resort to a liquid diet for a few days, and  today he states that he still has some minor  mouth soreness
At 9:25PM the night after his first dose vaccine I heard a noise from his room. I found him unresponsive and his entire body shaking. He was having a seizure that lasted about a minute and a half. His postictal state was about 20 minutes. He did not have a fever and his glucose was normal. We went to the hospital. They did a work-up and assessment. They set him up with neurology. He is on KEPPRA for at least 2 years to ensure he does not have any more seizures. He did receive his second dose in December 2021 but he was already on KEPPRA.
~2in radius (uneven) rash, swelling, inflammation at vaccine site. Began ~24-36hr after first shot. Swelling went down after 72hr but returned, a deeper red, and itchy, one week after the shot. Also have sore muscles under the arm, and a swollen lymph node on the shoulder near it, inside the collarbone.
3:00 AM- Woke up with a headache, eyes hurting 3:30 AM- Alarm goes off for Saturday work, found self couldn't keep my balance, felt hot 3:38 AM- Temp read 104° F, drank 8 Ounce of water and some Gatorade, called in sick for work and laid back down. 3:40 AM- Vomiting, sweating, knees aching and felt weak and dehydrated.  7:13 AM- Arived at IU, got some meds to help with headaches and keeping fluids down
HIVES APPEARED ON PATIENT'S ABDOMEN AREA AND UPPER THIGHS AROUND ONE IN THE MORNING, PATIENT'S MOTHER CALLED THE ON CALL DOCTOR FOR OUR FACILITY, WAS INSTRUCTED TO TREAT WITH BENADRYL.
Localized erythema, edema and warmth to site that may be cellulitis. Onset same day, worsened over the course of the next 48 hours.
1JUN94 pt exp sz;pt to MD 7JUN94 MD dx ear infect & colic; pt given med;pt still fussy & irritable;taken to another MD who felt pt had colic given another med;later sz discovered;sz or infantile spasms, asthma;pt devel delayed;hx pneumonia;
Patient is 12 years old.  On 12/11/21 patient presented vaccination card for second vaccine of Pfizer.  On vaccine card is was noted that on 11/20/21, patient received pediatric Pfizer covid vaccine.  After professional medical consultation it was determined to complete the vaccination series with the pediatric dose.  Therefore, patient received second dose on 12/11/21 as the pediatric formulation.  There was no adverse affect,
During charting of above administered vaccines, noted patient had received 4 year well vaccines two days prior on 10/24 (mom had marked "no" to vaccines in prior 4 weeks on screening form, and printed vaccine records available at time of visit did not list vaccines from 10/24. Vaccines received in duplicate: Fluzone, Lot UJ879AB, given in Left thigh on 10/24/22. MMRV, Lot W020548, given in Right thigh on 10/24/22. Kinrix, Lot 2kl4k, given in Left thigh on 10/24/22.
pt recvd vax & devel demyelinizing disease; at time of rept, pt completely disabled;
This spontaneous report was received from a physician and from a support services director and refers to a patient of unknown age and gender. No information regarding the patient's medical history and concurrent conditions was provided. On 03-JUN-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 injection (lot # J011042, expiry date: 04-MAR-2015; exact dose and route of administration were not reported). There were no concomitant therapies reported. On an unknown date, the dose of the vaccine was exposed to the temperature excursion lasting 672 hours with the lowest recorded temperature of 20 degrees Fahrenheit (-6.66 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a patient who received FLULAVAL QUADRIVALENT. On an unknown date, the patient received FLULAVAL QUADRIVALENT .5 ml. On an unknown date, unknown after receiving FLULAVAL QUADRIVALENT, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to FLULAVAL QUADRIVALENT. Additional information was provided as follows: The age at vaccination was not reported. The pharmacist reported that the physician wanted her to split the 0.5 ml dose of FLULAVAL QUADRIVALENT into 2 separate doses and give 0.25 ml of FLULAVAL QUADRIVALENT at separate visits. The healthcare professional wanted to know would this effect the integrity or what the effect would be on the patient if they received 0.25ml of FLULAVAL QUADRIVALENT at separate visits. The healthcare professional stated that the patient had a reaction to the 0.5 ml dose however, healthcare professional did not have any information on what the reaction was nor any patient information nor if it was for sure FLULAVAL QUADRIVALENT 0.5 ml that the patient had a reaction to. No further information was provided.
February 9,2021 I went see my caediologist complaining shortness of breath and little energy.  We laid rhis off to lack of excercise due ro quarantine from Covid.  By April 6 I was so short of breath,my wife insisted that I see my PCP.  He found that my O2 was at  77%, he immediately called my cardiologist and explained my symptoms which resulted in my hospitalization.  After six days of testing, the diagnosis being "Acute respiratory failure with hypoxia  (HCC) J96. and Diastolic dysfuntion (151.89)
Allergic reaction; Syringe malfunctioned and the vaccine ran down patients arm/ noticed there was still some vaccine left in the syringe; Syringe malfunctioned and the vaccine ran down patients arm/ noticed there was still some vaccine left in the syringe; Administered another new dose; A spontaneous report was received on 12 FEB 2021 from a pharmacist concerning a 36-years-old, female patient who received second dose of Moderna's COVID-19 vaccine and had syringe malfunctioned and the vaccine ran down patients arm/ noticed there was still some vaccine left in the syringe developed allergic reaction, heart racing, arm was on fire and throat was itchy and was administered another new dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unspecified date, the patient received their first of two planned doses of mRNA-1273 on 28 Jan 2021 (LOT number: unknown) for COVID-19 infection prophylaxis. On 28 JAN 2021, patients received second dose of mRNA-1273(BATCH/LOT number: 025J20-2A) in the right upper arm for the prophylaxis of COVID-19 infection.  On 28 JAN 2021, when patient received the vaccine, the syringe was "malfunctioned", and the vaccine ran down patient's arm. Vaccine administrator noticed there was still some vaccine left in the syringe and thought the patient did not receive that dose because it was leaked down patients arm. The patient received another new dose. After receiving vaccine, patient had an allergic reaction, heart racing, arm was on fire and throat was itchy. Treatment for the events provided was diphenhydramine.   Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of the event's allergic reaction, heart racing, arm was on fire and throat was were unknown. The outcome of the events syringe malfunctioned, and the vaccine ran down patients arm noticed there was still some vaccine left in the syringe developed and administered another new dose were considered resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
None.  Possible adverse reaction to MMR to child status post renal transplant and on immunosuppresants.
Information has been received from a pharmacist concerning a HIV patient who was vaccinated with PNEUMOVAX 23 and had more of a swollen arm and fever than normal.  The patient had sought unknown medical attention.  At the time of report the patient's status was unknown.  This is one of several reports from the same source.  Additional information has been requested.
Received PNEUMOVAX in the clinic as per protocol and returned to clinic with swelling and pain left upper arm. NO rash, itching or dyspnea. No wheeze. Swelling of left deltoid at injection site with tenderness and mild warmth. No bruising or bleeding.
HYPOTENSION 12/30/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Day 2 - I was feeling a little dizzy and my stomach was not feeling good.  Later in the day my stomach started cramping and I had to use the restroom 4 times before the day was over having diarrhea.  My shoulder was very sore and painful day 1 and 2. Day 3 - Shoulder is a little sore and headaches off and on minor diarrhea.
Patient had increased fussiness and abdominal pain with significantly increased crying and leg raising. He came to the emergency department at the Hospital, where he had a KUB (showed increased stool burden), ultrasound (showed target sign with small bowel to small bowel intussusception, but couldn't rule out ileocolonic), and a fluoroscopic intussusception reduction enema which revealed that there was no intussusception, so presumably it self resolved.
Day 1 (evening) -- vax Day 2 & 3 -- high fever (101, my normal 97.4), anorexia, weakness, curled up in bed Day 4 & 5 -- low energy, achey, more soreness in arm, itchiness, moderate fever (99-100) Day 6 -- tired, arm still itchy and sore, temp normal Day 7 -- felt GOOD, resumed normal activities Day 8-10 -- moderate-to-severe headache (which I never get), fever on and off (99-100) Day 11 ---- > present (Day 33) -- mostly recovered but occasional slight headache and occasional dizziness
Very bad headache mostly over the left eye. Was migraine in nature. I was light sensitive & throwing up. Took ibuprofen & Tylenol and drank over 32 ounces of water & went to bed. Headache was gone the next morning & returned in the afternoon but not as severe. There was also discomfort at the injection site.
20 minutes after the vaccine the patient felt pain in the right neck and generalized discomfort all over. Allergy called. Vitals taken. Allergy recommended additional 15 minutes of monitoring. No improvement so the patient was transferred to ED for further evaluation.
PATIENT RECEIVED WRONG DOSE OF VACCINE AT ADMINISTRATION. PATIENT RECEIVED 1ML INSTEAD OF 0.5ML DOSE. NO S/SX OF ADVERSE EFFECTS NOTED AT THIS TIME.
Breakthrough case admission after 3 vaccines Pfizer 3/1921 Lot# En6200;  Pfizer 4/10/21 Lot# ER8733;  Pfizer 11/3/21 Lot# FF2593
Initial report received on 01 May 2007 from a health care professional. A neonate patient had received on 05 December 2006, transplacental vaccination with Menactra (lot# U1809AA), 0.5 ml intra-muscular into the right deltoid, and Gardasil (lot# 0868F), 0.5 ml intra-muscular into the left deltoid. The patient's mom was unaware of pregnancy prior, therefore did not have prenatal care. The patient's mother experienced abdominal pain prior to going to the hospital and took hydrocodone prior to going to the hospital, when she delivered a baby on 23 April 2007. Meconium stated upon delivery. Baby was having seizures and was transferred to neonatal care where baby remained. The reporter denied that the patient's mother was on current medications. The patient's mother medical history included recurrent tonsillitis. The mother case number is 2007-01504.
covid 19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (covid 19) in a male patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     The patient's past medical history included Lymphoma. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccine (Dose 1), Moderna COVID-19 vaccine (Dose 6), Moderna COVID-19 vaccine (Dose 5), Moderna COVID-19 vaccine (Dose 3), Moderna COVID-19 vaccine (Dose 2) and Moderna COVID-19 vaccine (Dose 4); for Product used for unknown indication: Janssen vaccine (2 out of 2) and Janssen vaccine (1 out of 2). Past adverse reactions to the above products included No adverse event with Janssen vaccine, Janssen vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine, Moderna COVID-19 vaccine and Moderna COVID-19 vaccine.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient received a monoclonal antibody treatment.   Reporter did not allow further contact
After receiving the vaccine I had the normal side effects, pain at injection site for about 24 hours.  On day 9 after the vaccine, January 23, 2020, I developed a 3 inch bed blotch under the skin that does not itch but is warm and tender to touch.  I?ve tried topical ointments like Benadryl and Bacitracin but as of today January 26, 2021 it is still the same.
Soreness, swelling and redness at injection site starting 24 hours after injection and continuing at the time of this report.
Information has been received from a medical assistant referring to a 69 year old male patient. The patient's concurrent condition included cardiac failure congestive (CHF). Concomitant therapys included atorvastatin, amlodipine, losartan potassium (manufacturer unknown) and acetaminophen, chlorpheniramine maleate, aspirin (manufacturer unknown). Medical history was not reported. The patient had no drug reactions/allergies. On 29-NOV-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # M032635, expiration date: 20-MAY-2018, dose and route were unknown). On 30-NOV-2016 the patient came to office and had redness and swelling at injection site. The patient "wasn't feeling well", and was admitted to a hospital and diagnosed with new onset atrial fibrillation. Unspecified treatments were given for the events. The outcome of the events were unknown. Causality was not provided. The reporter was requesting lot check. Upon internal review, atrial fibrillation was determined to be medically significant. This is one of several reports received from the same reporter. Additional information has been requested.
Patient was not 65 years old when he received the vaccination. He turns 65 in 4 days.